Stroke is one of the leading causes of death around the world. New devices have been developed for treatment of ischemic acute intracranial occlusions. We present our case series of patients with acute ischemic stroke treated by endovascular techniques at our institution.
We reviewed retrospectively medical records of patients with acute ischemic stroke in large vessels in cerebral territories that received endovascular treatment between January 2012 and April 2013. Endovascular treatment consisted of pharmacological and/or mechanical intervention, or a combination of these methods.
We reviewed records of 5 patients treated between September 2012 and April 2013. 2 males and 3 females, median age 50.8 years. Mean baseline NIHSS score was 9.4. The estimated median interval from stroke onset to anesthesia was 210 minutes, except for 1 case with cerebral sinus thrombosis which was admitted 7 days before by another department and after our evaluation was taken for endovascular treatment in less than two hours. 3 cases were M1 occlusions, 1 case A3 and M2 occlusions after vasospasm to contrast media and shower of thrombi, and another was CVST secondary to tetrahydrofolate reductase mutation. Endovascular therapy was as follows: 2 cases with Reopro, 2 cases with the Solitaire® + Reopro and 1 case with tPA + Verapamil. TIMI score before therapy was 0/1 and after 2AB or 3. Median mRS score was 4 including 1 mortality.
We performed treatment for acute ischemic stroke in a safe and efficacious fashion. Early diagnosis, careful patient selection and fast intervention are key to obtaining a good clinical outcome.
Improvement Stroke algorithm regarding acute endovasculat intervention
Acute endovascular stroke management